Xi’An Hex Life Sciences Ltd

Interests associated with CEM own a majority shareholding in the Chinese corporation Xi’An Hex Life Sciences Ltd (XHLS) acquired as part of the purchase of the former Australian public company Narhex Life Sciences Ltd.

Based in the city of Xi’An in the Chinese province of Shaanxi, XHLS has pursued the development of a drug, initially of Australian origin, for the treatment of HIV AIDS. That development work continues and XHLS is currently seeking interest from Chinese pharmaceutical companies and others working in the field of AIDS treatment.

Xi'An Life Sciences 2

CEM is currently examining opportunities in non-Chinese medical diagnostic equipment, with a view to marketing such equipment in China.

 

 

back to top